AstraZeneca buys biotech CinCor for up to USD1.8 billion
(Alliance News) - AstraZeneca PLC on Monday said it has acquired CinCor Pharma Inc for an upfront cash consideration of approximately USD1.3 billion, although the fee could rise to USD1.8 billion .
AstraZeneca is a science-driven…